Background
==========

Obesity is a common problem in the United States that independently confers risk for chronic disease and early mortality \[[@B1]\]. Several studies address the importance of recognition and treatment of obesity in chronic disease management, but few evaluate body mass index (BMI) assessment and risk factor documentation and control in patients who are obese both with and without cardiovascular disease (CVD), diabetes or risk factors \[[@B2]-[@B6]\].

Assessments of BMI and CVD or diabetes risk factors are simple, inexpensive tools that can be used by primary care physicians (PCPs) to address obesity and its complications. Little consensus exists in current guidelines concerning the need to screen for BMI and associated risk factors \[[@B7]-[@B15]\]. In 1998 the National Heart, Lung, and Blood Institute (NHLBI) established guidelines for BMI and risk factor measurement in all patients under 80 years of age with the goal of implementation of strategies for weight loss and risk factor control in patients with a BMI of ≥ 30 kg/m^2^or 25-29.9 kg/m^2^and ≥ two risk factors \[[@B10]\]. In 2007 the National Committee for Quality Assurance (NCQA) organized field tests of a prospective Healthcare Effectiveness Data and Information Set (HEDIS) measure to assess the percentage of members 18-74 years of age with an outpatient visit, and who had BMI documented and risk factors documented if found to have a BMI of ≥30 kg/m^2^\[[@B16]\]. Their work led to the proposed HEDIS 2009 measure *BMI Assessment*\[[@B17]\], which is proposed for reporting by commercial, Medicaid, and Medicare plans.

Given the magnitude and clinical impact of the current obesity epidemic and its risk factors, and the potential implementation of the HEDIS *BMI Assessment*measure, we aimed to examine current care in BMI and risk factor assessment for patients in a large network of primary care practices that use a common electronic health record (EHR). We investigated the prevalence of BMI measurement and documentation and control of the CVD and diabetes risk factors blood pressure (BP), low density lipoprotein (LDL), and fasting and casual glucose. We examined these risk factors according to the BMI categories normal weight, overweight, and obese. We hypothesized that documentation of BMI would vary widely in clinical practice, and that patients who were obese would be more likely to have better documentation, but poorer control, of risk factors than patients of normal weight.

Methods
=======

Setting and Patients
--------------------

We identified 138,933 patients in our primary care research network of twelve practices that make up the Massachusetts General Hospital Primary Care Practice Based Research Network (PBRN). Practices include urban academic faculty practices, private offices, and community health centers in and around Boston, Massachusetts. These twelve practices use a common EHR that contains all clinical and utilization data for each patient. The data from the EHR data are searchable in the Research Patient Data Repository (RPDR) \[[@B18]\]. From these, we included 79,947 patients who were at least 18 years of age and had at least two clinic visits billed to their PCP between 7/1/05 and 12/31/06, and did not have a height greater than or equal to seven feet (2.13 meters), weight \<70 or \>1000 pounds (\<31.8 or \>453.6 kilograms), systolic BP \<50 or \>260 mmHg, or diastolic BP \<30 or \>150 mmHg. The study was approved by the Partners Health Care System Institutional Review Board.

BMI Measurement
---------------

The intent of the HEDIS initiative is to measure and increase documentation of BMI. We obtained BMI from height and weight data recorded in the EHR, where they are used to automatically calculate and display BMI. For this analysis we calculated BMI from the most recent weight in the 18-month period and the most recent height prior to 12/31/06 from structured coded entries in the EHR. For completeness, we also searched the text of narrative notes in the EHR using a validated Natural Language Processing abstraction tool that computationally abstracts weight, height, and BP values from the free text of clinician notes \[[@B19],[@B20]\]. The sensitivity and specificity of the approach to abstraction (compared with a trained chart abstractor) are 87.9% and 99% for detection of height, 91.8% and 92.1% for detection of weight, and 91% and 96% for detection of BP \[[@B19],[@B20]\]. Because of high rates of missing heights, we confirmed with clinic site medical directors that we had searched in all the appropriate places in the clincial record for height and weight information.

We categorized BMI using Centers for Disease Control (CDC) definitions, with underweight equal to BMI \<18.5 kg/m^2^, normal weight equal to a BMI of 18.5-\<25 kg/m^2^, overweight BMI equal to 25-\<30 kg/m^2^, and obese BMI ≤30 kg/m^2^\[[@B21]\]. We included underweight patients when measuring documentation of BMI, but excluded them otherwise. Among those with a documented BMI, we examined documentation and control of three risk factors: blood pressure (BP), LDL cholesterol, and fasting or casual glucose levels, or both. We examined risk factor documentation and control in the clinic population overall, and stratified by three BMI categories.

Risk Factor, CVD, and Diabetes Measurement
------------------------------------------

Documentation of a risk factor was defined as being found in the EHR at least once within the study period. If a risk factor was documented more than once, we used the most recently documented value. A risk factor was defined as controlled if within normal range, defined as: BP ≤130/≤85 mmHg, LDL\<130 mg/dL (3.367 mmol/L), and fasting glucose \<100 mg/dL (5.55 mmol/L) or casual glucose \<200 mg/dL (11.1 mmol/L) \[[@B22]-[@B24]\]. We also measured documentation and control of all three risk factors combined as an aggregate measure of risk factor management.

We defined clinical CVD as coronary artery disease, cerebrovascular accident, or peripheral vascular disease listed on the EHR Problem List, or as having two outpatient or one inpatient International Classification of Diseases, Ninth Revision (ICD-9) codes for CVD. We defined clinical diabetes as diabetes on the EHR problem list and a diabetes medication on the medication list, or as having two outpatient or one inpatient codes related to diabetes. The definitions of diabetes, hypertension, hyperlipidemia and CVD have previously been validated \[[@B25],[@B26]\]. For instance, the sensitivity of our approach for diabetes or CVD are \>98% and specificity of \>97% compared to the gold standard of trained research nurse chart abstraction. We used the same approach as for diabetes to define hypertension and hyperlipidemia. Other measurements included age, race, gender, number of PCP visits during the study period, insurance type, and clinic site.

Statistical Analysis
--------------------

We conducted a cross-sectional analysis. We measured rates of BMI documentation in each clinic site and overall. Among those with a BMI, we measured risk factor documentation and control overall, and stratified by the three BMI categories. We further stratified the analysis by the presence or absence of CVD or diabetes. We used generalized linear models or chi-square tests to test levels or rates of characteristics by BMI category. We used the Breslow Day test for homogeneity of odds ratios to test for effect modification of CVD or diabetes on the association of BMI with risk factor documentation and control. We used SAS version 9.1 (Cary, NC) for all analyses, and considered a p value of \<0.05 to indicate statistical significance.

Results
=======

BMI Documentation and Characteristics of Patients with Documented BMI
---------------------------------------------------------------------

Of 79,947 patients, 72,633 (90.9%) had an available weight, 50,345 (63.0%) had an available height, and 48,376 (60.5%) had both height and weight recorded to calculate BMI (Table [1](#T1){ref-type="table"}). Of those with BMI present, 14,290 patients (30%) were classified as obese, 16,402 (34%) overweight, 16,936 (36%) normal weight, and 748 (2%) underweight. Compared to those missing BMI, patients with BMI documented were younger, had a higher mean number of PCP visits, were more likely to be women, and were more likely to have commercial insurance or Medicare than patients without a BMI (p \< 0.0001 for all; Table [2](#T2){ref-type="table"}). As expected, patients with obesity were older, less likely to be women, white, or to have private insurance or Medicare, had a higher mean number of PCP visits, and were more likely to have a history of CVD, diabetes, hypertension, and dyslipidemia than patients of normal weight (p \< 0.0001 for all; Table [3](#T3){ref-type="table"}).

###### 

Body Mass Index Documentation in 79,947 Patients in 12 Primary Care Clinics

  Clinic        N              BMI          Height Documented   Weight Documented
  ------------- -------------- ------------ ------------------- -------------------
                               **%**        **%**               **%**
  **1**         **3,027**      93.5         94.1                99.1
  **2**         **4,559**      89.8         95.7                91.6
  **3**         **3,274**      86.9         87.5                99.1
  **4**         **3,989**      85.8         94.5                87.4
  **5**         **1,344**      75.1         75.2                99.5
  **6**         **7,747**      65.8         66.0                99.0
  **7**         **21,299**     64.0         65.8                96.1
  **8**         **3,962**      55.4         55.8                98.7
  **9**         **12,919**     50.2         55.4                71.1
  **10**        **4,781**      41.9         44.4                78.4
  **11**        **8,052**      38.2         38.3                99.0
  **12**        **4,994**      34.0         35.7                88.9
  ***Total***   ***48,376***   ***60.5***   ***63.0***          ***90.9***

Data are ranked by BMI documentation rate, include patients at least 18 years of age with at least two clinic visits billed to their PCP between 7/1/05 and 12/31/06, and include underweight patients (BMI \<18.5 kg/m^2^) excluded from the main analysis. BMI = Body Mass Index (weight in kilograms/height in meters^2^)

###### 

Patient Demographics and Clinical Characteristics in 79,947 Patients in 12 Primary Care Clinics by Documentation or Missingness of BMI

  Characteristic                                                                                      BMI Documented   48,376         BMI not Documented   31,571     P value
  -------------------------------------------------------------- --------------------- -------------- ---------------- -------------- -------------------- ---------- --------------
  **Clinic**                                                     **n**                 **%**                                                                          **\<0.0001**
   **1**                                                                                              2,830            5.9            197                  0.6        
   **2**                                                                                              4,093            8.5            466                  1.5        
   **3**                                                                                              2,844            5.9            430                  1.4        
   **4**                                                                                              3,421            7.1            568                  1.8        
   **5**                                                                                              1,009            2.1            335                  1.1        
   **6**                                                                                              5,095            10.5           2,652                8.4        
   **7**                                                                                              13,630           28.2           7,669                24.3       
   **8**                                                                                              2,194            4.5            1,768                5.6        
   **9**                                                                                              6,489            13.4           6,431                20.4       
   **10**                                                                                             2,003            4.1            2,778                8.8        
   **11**                                                                                             3,073            6.4            4,979                15.8       
   **12**                                                                                             1,696            3.5            3,298                10.5       
  **Age**                                                        **mean years**        51                              53                                  \<0.0001   
  **Women**                                                      n                     \%             31,412           64.9           15,986               50.6       \<0.0001
  **Race**                                                       n                     \%                                                                             \<0.0001
   **White**                                                                                          37,625           77.8           25,264               80.0       
   **Asian**                                                                                          2,057            4.3            1,426                4.5        
   **Black**                                                                                          2,908            6.0            1,464                4.6        
   **Hispanic**                                                                                       4,123            8.5            2,397                7.6        
  **Number of PCP visits**                                       **mean**              **range**      4.2              (2-61)         3.9                  (2-56)     \<0.0001
  **Commercial Insurance or Medicare**                           **n**                 **%**          42,740           88.4           27,522               87.2       \<0.0001
  **History of CVD**                                             **n**                 **%**          7,298            15.1           4,989                15.8       0.0060
  **History of diabetes**                                        **n**                 **%**          5,872            12.1           3,453                10.9       \<0.0001
  **History of hypertension**                                    **n**                 **%**          22,121           45.7           14,698               46.6       0.02
  **History of dyslipidemia**                                    **n**                 **%**          25,698           53.1           17,133               54.3       0.002
  **HbA1c**                                                      **%**                                6.7                             6.8                             0.0001
  **Blood pressure**                                             **mean mmHg**         122/75                          123/74                              \<0.0001   
  **Total cholesterol**                                          mean mg/dL (mmol/L)   188.1 (4.87)                    188.5 (4.88)                        0.29       
  **LDL**                                                        mean mg/dL (mmol/L)   104.1 (2.70)                    105 (2.72)                          0.001      
  **HDL**                                                        mean mg/dL (mmol/L)   59.3 (1.54)                     57.8 (1.50)                         \<0.0001   
  **Triglyceride level**                                         mean mg/dL (mmol/L)   127.8 (1.44)                    132.6 (1.50)                        \<0.0001   
  **Casual glucose**                                             mean mg/dL (mmol/L)   101.8 (5.65)                    100.8 (5.59)                        0.0007     
  **Fasting glucose**                                            mean mg/dL (mmol/L)   102.4 (5.68)                    100.9 (5.60)                        0.0007     
                                                                                                                                                                      
  **Risk factor documentation**                                  **Total n**           **%**                                                                          
                                                                                                                                                                      
  **Blood Pressure**                                             64,204                80.3           37,489           77.5           26,715               84.6       \<0.0001
  **LDL**                                                        55,210                69.1           33,788           69.8           21,422               67.9       \<0.0001
  **Casual glucose**                                             56,984                71.3           35,125           72.6           21,859               69.2       \<0.0001
  **Fasting glucose**                                            21,533                26.9           13,533           28.0           8,000                25.3       \<0.0001
  **HbA1c**                                                      14,252                17.8           9,367            19.4           4,885                15.5       \<0.0001
  **Total cholesterol**                                          58,951                73.7           36,247           74.9           22,704               71.9       \<0.0001
  **HDL**                                                        58,373                73.0           35,874           74.2           22,499               71.3       \<0.0001
  **Triglycerides**                                              55,948                70.0           34,247           70.8           21,701               68.7       \<0.0001
                                                                                                                                                                      
  **Risk factor control in those with documented risk factor**   **Total n**           **%**                                                                          
                                                                                                                                                                      
  **Blood Pressure \<130 and \< 85 mmHg**                        46,748                72.8           27,212           72.6           19,536               73.1       0.13
  **LDL \<130 mg/dL**                                            43,369                78.6           26,656           78.9           16,713               78.0       0.015
  **Casual glucose \< 200 mg/dL**                                55,642                97.6           34,231           97.5           21,411               98.0       0.0001
  **Fasting glucose \< 100 mg/dL**                               13,782                64.0           8,574            63.4           5,208                65.1       0.01
  **HbA1c \<7%**                                                 9,638                 67.6           6,463            69.0           3,175                65.0       \<0.0001
  **Total cholesterol \<200 mg/dL**                              37,279                63.2           22,952           63.3           14,327               63.1       0.59
  **HDL \>35 mg/dL (male) and \>40 mg/dL (female)**              52,971                90.8           32,742           91.3           20,229               89.9       \<0.0001
  **Triglycerides \<150 mg/dL**                                  48,188                86.1           29,675           86.7           18,513               85.3       \<0.0001

P-value compares BMI documented with BMI not documented. BMI = Body Mass Index (weight in kilograms/height in meters^2^), PCP = Primary Care Physician, CVD = Cardiovascular Disease, HbA1c = Hemoglobin A1C, LDL=low density lipoprotein cholesterol, HDL = high density lipoprotein cholesterol. LDL \<130 mg/dL = \<3.367 mmol/L; casual glucose \<200 mg/dL = \<5.55 mmol/L; fasting glucose \<100 mg/dL = \<11.1 mmol/L

###### 

Characteristics of 47,628 Primary Care Patients by BMI Category

  Characteristic                                         Obese    n = 14,290   Overweight   n = 16,402   Normal   n = 16,936   P value
  ----------------------------------- ------------------ -------- ------------ ------------ ------------ -------- ------------ ----------
  **Age**                             **(mean years)**   53       53           48           \<0.0001                           
  **Number of PCP visits**            **(mean)**         4.7      4.2          3.9          \<0.0001                           
  **Women**                           **n (%)**          8,565    59.9         8,899        54.3         13,272   78.4         \<0.0001
  **Race\***                          **n (%)**                                                                                \<0.0001
   **White**                                             10,712   75.0         12,674       77.3         13,655   80.6         
   **Asian**                                             179      1.3          567          3.5          1,229    7.3          
   **Black**                                             1,244    8.7          989          6.0          649      3.8          
   **Hispanic**                                          1,722    12.1         1,561        9.5          811      4.8          
  **Private Insurance or Medicare**   **n (%)**          12,104   84.7         14,502       88.4         15,467   91.3         \<0.0001
  **History of CVD**                  **n (%)**          2,647    18.5         2,699        16.5         1,862    11.0         \<0.0001
  **History of diabetes**             **n (%)**          3,238    22.7         1,789        10.9         824      4.9          \<0.0001
  **History of hypertension**         **n (%)**          9,116    63.8         7,895        48.1         4,931    29.1         \<0.0001
  **History of dyslipidemia**         **n (%)**          9,235    64.6         9,495        57.9         6,769    40.0         \<0.0001

P-value is for general association across BMI categories. BMI = Body Mass Index (weight in kilograms/height in meters^2^), PCP = Primary Care Physician, and CVD = Cardiovascular Disease. \*Designation \"Other\" for race deleted from set.

Documentation and Control of Risk Factors
-----------------------------------------

Overall, less than 78% had at least one risk factor documented and just half had all three documented (Table [4](#T4){ref-type="table"}, Figure [1](#F1){ref-type="fig"}). Of these, about half of all patients had all three risk factors controlled (Figure [1](#F1){ref-type="fig"}). Documentation of all three risk factors was higher in obesity than in overweight or normal weight (p \< 0.0001), but control of all three risk factors was lower, (p \< 0.0001), with only 44% of patients with obesity having all risk factors under control.

###### 

Documentation and Control of Risk Factors among 47,628 Primary Care Patients, by BMI Category

  Risk Factor Documentation          Total       n = 47,628   Obese            n = 14,290   Overweight    n = 16,402   Normal   n = 16,936   P value
  ---------------------------------- ----------- ------------ ---------------- ------------ ------------- ------------ -------- ------------ ----------
                                     **n**       **%**        **n**            **%**        **n**         **%**        **n**    **%**        
                                                                                                                                             
  **BP**                             36,934      77.6         10,900           76.3         12,890        78.6         13,144   77.6         \<0.0001
  **LDL**                            33,427      70.2         11,239           78.7         12,013        73.2         10,175   60.1         \<0.0001
  **Casual Glucose**                 34,589      72.6         11,216           78.5         11,901        72.6         11,472   67.7         \<0.0001
  **Fasting Glucose**                13,421      28.2         5,347            37.4         4,804         29.3         3,270    19.3         \<0.0001
                                                                                                                                             
  **Risk Factor Control**            **Total**   **Obese**    **Overweight**   **Normal**   **P value**                                      
                                                                                                                                             
                                     **n**       **%**        **n**            **%**        **n**         **%**        **n**    **%**        
                                                                                                                                             
  **BP \<130 and \< 85 mmHg**        26,736      72.4         6,801            62.4         9,202         71.4         10,733   81.7         \<0.0001
  **LDL \<130 mg/dL**                26,328      78.8         8,777            78.1         9,273         77.2         8,278    81.4         \<0.0001
  **Casual glucose \< 200 mg/dL**    33,698      97.4         10,707           95.5         11,635        97.8         11,356   99.0         \<0.0001
  **Fasting glucose \< 100 mg/dL**   8,482       63.2         2,753            51.5         3,146         65.5         2,583    79.0         \<0.0001

P-value is for general association across BMI categories. BMI=Body Mass Index (weight in kilograms/height in meters²); LDL \<130 mg/dL=\<3.367 mmol/L; casual glucose \<200 mg/dL=\<5.55 mmol/L; fasting glucose \<100 mg/dL=\<11.1 mmol/L.

![**Documentation and control of all three risk factors by BMI category**. A. Documentation of all 3 risk factors by BMI category; B. Documentation of all 3 risk factors by BMI category, stratified by history of CVD; C. Documentation of all 3 risk factors by BMI category, stratified by history of diabetes. D. Control of all 3 risk factors by BMI category; E. Control of all 3 risk factors by BMI category, stratified by history of CVD; F. Control of all 3 risk factors by BMI category, stratified by history of diabetes.](1472-6963-9-236-1){#F1}

The presence of CVD or diabetes modified some associations of BMI category with risk factor documentation and control. In patients with CVD or diabetes, the rates of documentation were generally less different comparing patients with obesity with those of normal weight, while in patients without CVD or diabetes, rates of documentation were strikingly higher in patients with obesity than normal weight (Figure [1](#F1){ref-type="fig"}, Table [5](#T5){ref-type="table"}, p = 0.26 to \<0.0001 for CVD- or diabetes-by-BMI category interaction). Likewise, in patients with CVD or diabetes the rates of control were generally less different comparing patients with obesity with those with normal weight, but in patients without CVD or diabetes, rates of control were strikingly lower in patients with obesity than normal weight (Figure [1](#F1){ref-type="fig"}, Table [6](#T6){ref-type="table"}). Overall 50% or fewer of the patients with obesity and CVD or diabetes had all three risk factors under control (Figure [1](#F1){ref-type="fig"}, Tables [5](#T5){ref-type="table"} and [6](#T6){ref-type="table"}).

###### 

Documentation of Risk Factors in 47,628 Patients in 12 Primary Care Clinics Stratified by BMI Category and History of CVD or Diabetes

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Risk Factors                  Total    Obese   n = 14,290                       Overweight                       n = 16,402                       Normal Weight   n = 16,936   P value   
  ----------------------------- -------- ------- -------------------------------- -------------------------------- -------------------------------- --------------- ------------ --------- ----------
                                                                                                                                                                                           

  **History of CVD**            **n**    **%**   **n**                            **%**                            **n**                            **%**           **n**        **%**     

   **H/O CVD n = 7,208**                         **H/O CVD N = 2,647**            **H/O CVD N = 2,699**            **H/O CVD N = 1,862**                                                   

   **NO H/O CVD n = 40,420**                     **No H/O CVD N = 11,643**        **NO H/O CVD N = 13,703**        **NO H/O CVD N = 15,074**                                               

                                                                                                                                                                                           

                                                                                                                                                                                           

  **BP**                                         **n = 10,900**                   **n = 12,890**                   **n = 13,144**                                                          

   **H/O CVD**                  5,297    73.5    1,931                            73.0                             1,991                            73.8            1,375        73.9      0.26

   **NO H/O CVD**               31,637   78.3    8,969                            77.0                             10,899                           79.5            11,769       78.1      

  **LDL**                                        **n = 11,239**                   **n = 12,013**                   **n = 10,175**                                                          

   **H/O CVD**                  6,199    86.0    2,393                            90.4                             2,358                            87.4            1,448        77.8      0.15

   **NO H/O CVD**               27,228   67.4    8,846                            76.0                             9,655                            70.5            8,727        57.9      

  **Casual glucose**                             **n = 11,216**                   **n = 11,901**                   **n = 11,472**                                                          

   **H/O CVD**                  6,305    87.5    2,355                            89.0                             2,322                            86.0            1,628        87.4      0.0001

   **NO H/O CVD**               28,284   70.0    8,861                            76.1                             9,579                            69.9            9,844        65.3      

  **Fasting glucose**                            **n = 5,347**                    **n = 4,804**                    **n = 3,270**                                                           

   **H/O CVD**                  2,741    38.0    1,158                            43.8                             1,023                            37.9            560          30.1      \<0.0001

   **NO H/O CVD**               10,680   26.4    4,189                            36.0                             3,781                            27.6            2,710        18.0      

  **All 3 risk factors**                         **n = 8,247**                    **n = 8,797**                    **n = 6,986**                                                           

   **H/O CVD**                  4,417    61.3    1,696                            64.1                             1,693                            62.7            1,028        55.2      \<0.0001

   **NO H/O CVD**               19,613   48.5    6,551                            56.3                             7,104                            51.8            5,958        39.5      

                                                                                                                                                                                           

                                                                                                                                                                                           

  **History of DM**                              n                                \%                               n                                \%              n            \%        

   **H/O diabetes n = 5,851**                    **H/O diabetes N = 3,238**       **H/O diabetes N = 1,789**       **H/O diabetes N = 824**                                                

   **NO H/O diabetes**\                          **NO H/O diabetes N = 11,052**   **NO H/O diabetes N = 14,613**   **NO H/O diabetes N = 16,112**                                          
  **n = 41,777**                                                                                                                                                                           

                                                                                                                                                                                           

                                                                                                                                                                                           

  **BP**                                         **n = 10,900**                   **n = 12,890**                   **n = 13,144**                                                          

   **H/O diabetes**             4,398    75.2    2,447                            75.6                             1,366                            76.4            585          71.0      0.002

   **NO H/O diabetes**          32,536   77.9    8,453                            76.5                             11,524                           78.9            12,559       78.0      

  **LDL**                                        **n = 11,239**                   **n = 12,013**                   **n = 10,175**                                                          

   **H/O diabetes**             5,285    90.3    2,963                            91.5                             1,617                            90.4            705          86.2      0.51

   **NO H/O diabetes**          28,142   67.4    8,276                            74.9                             10,396                           71.1            9,470        58.8      

  **Casual glucose**                             **n = 11,216**                   **n = 11,901**                   **n = 11,472**                                                          

   **H/O diabetes**             5,225    89.3    2,884                            89.1                             1,596                            89.2            745          90.4      \<0.0001

   **NO H/O diabetes**          29,634   70.9    8,332                            75.4                             10,305                           70.5            10,727       66.6      

                                                                                                                                                                                           

  **Fasting glucose**                            **n = 5,347**                    **n = 4,804**                    **n = 3,270**                                                           

   **H/O diabetes**             2,736    46.8    1,619                            50.0                             812                              45.4            305          37.0      0.003

   **NO H/O diabetes**          10,685   25.6    3,728                            33.7                             3,992                            27.3            2,965        18.4      

  **All 3 risk factors**                         **n = 8,247**                    **n = 8,797**                    **n = 6,986**                                                           

   **H/O diabetes**             3,936    67.3    2,197                            67.9                             1,240                            69.3            499          60.6      0.001

   **NO H/O diabetes**          20,094   48.1    6,050                            54.7                             7,557                            51.7            6,487        40.3      
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

P-value compares homogeneity of odds ratios across groups. CVD = Cardiovascular Disease, BMI = Body Mass Index (weight in kilograms/height in meters^2^), BP = Blood Pressure, LDL = low density lipoprotein cholesterol, HDL = high density lipoprotein cholesterol. All 3 risk factors documented = documentation of BP + LDL + casual OR fasting glucose. Numbers and percentages in table reflect percentage of risk factor documented by BMI type in patients either with or without a history of CVD or DM (i.e., 1,931 = 73% of 2,647 patients who are obese with BP documented with a history of CVD).

###### 

Control of Risk Factors in 47,628 Patients in 12 Primary Care Clinics Stratified by BMI Category and History of CVD or Diabetes

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Outcome                        Total Documented           Total Controlled           Obese                                                    Overweight                              Normal                          P value
  ------------------------------ ------------------ ------- ------------------ ------- --------------------------- ---------------------------- ---------------------------- ---------- ----------------------- ------- ----------
  **History of CVD**             **n**              **%**   **n**              **%**   **n**                       **%**                        **n**                        **%**      **n**                   **%**   

  H/O CVD n = 7,208                                                                                                                                                                                                     

  NO H/O CVD\                                                                                                                                                                                                           
  n = 40,420                                                                                                                                                                                                            

                                                                                                                                                                                                                        

  BP \< 130 and \< 85 mmHg                                                             H/O CVD N = 1,931           H/O CVD N = 1,991            H/O CVD N = 1,375                                                       

                                                                                       NO H/O CVD 8,969            NO H/O CVD N = 10,899        NO H/O CVD N = 11,769                                                   

                                                                                                                                                                                                                        

                                                                                       n = 6,801                   n = 9,202                    n = 10,733                                                              

   H/O CVD                       5,297              73.5    3,338              63.0    1,155                       59.8                         1,256                        63.1       927                     67.4    \<0.0001

   NO H/O CVD                    31,637             78.3    23,399             74.0    5,647                       63.0                         7,946                        72.9       9,806                   83.3    

                                                                                                                                                                                                                        

  LDL \< 130 md/dL                                                                     H/O CVD N = 2,393           H/O CVD N = 2,358            H/O CVD N = 1,448                                                       

                                                                                       NO H/O CVD N = 8,846        NO H/O CVD N = 9,655         NO H/O CVD N = 6,989                                                    

                                                                                                                                                                                                                        

                                                                                       n = 8,777                   n = 9,273                    n = 8,278                                                               

   H/O CVD                       6,199              86.0    5,515              89.0    2,152                       89.9                         2,074                        88.0       1,289                   89.0    0.002

   NO H/O CVD                    27,228             67.4    20,813             76.4    6,625                       74.9                         7,199                        74.6       6,989                   80.1    

                                                                                                                                                                                                                        

  Casual glucose \< 200 mg/dL                                                          H/O CVD N = 2,355           H/O CVD N = 2,322            H/O CVD N = 1,628                                                       

                                                                                       NO H/O CVD N = 8,861        NO H/O CVD N = 9,579         NO H/O CVD N = 9,844                                                    

                                                                                                                                                                                                                        

                                                                                       n = 10,707                  n = 11,635                   n = 11,356                                                              

   H/O CVD                       6,305              87.5    5,979              94.8    2,173                       92.3                         2,218                        95.5       1,588                   97.5    0.13

   NO H/O CVD                    28,284             70.0    27,719             98.0    8,534                       96.3                         9,417                        98.3       9,768                   99.2    

                                                                                                                                                                                                                        

  Fasting glucose \< 100 mg/dL                                                         H/O CVD N = 1,158           H/O CVD N = 1,023            H/O CVD N = 560                                                         

                                                                                       NO H/O CVD N = 4,189        NO H/O CVD N = 3,781         NO H/O CVD N = 2,710                                                    

                                                                                                                                                                                                                        

                                                                                       n = 2,753                   n = 3,146                    n = 2,583                                                               

   H/O CVD                       2,741              38.0    1,325              48.3    415                         35.8                         561                          54.8       349                     62.3    0.0005

   NO H/O CVD                    10,680             26.4    7,157              67.0    2,338                       55.8                         2,585                        68.4       2,234                   82.4    

                                                                                                                                                                                                                        

  All 3 risk factors                                                                   H/O CVD N = 829             H/O CVD N = 1,693            H/O CVD N = 1,028                                                       

                                                                                       NO H/O CVD N = 2,767        NO H/O CVD N = 7,104         NO H/O CVD N = 5,958                                                    

                                                                                                                                                                                                                        

                                                                                       n = 3,596                   n = 4,344                    n = 4,327                                                               

   H/O CVD                       4,417              61.3    2,252              51.0    829                         48.9                         850                          50.2       573                     55.7    \<0.0001

   NO H/O CVD                    19,613             48.5    10,015             51.1    2,767                       42.2                         3,494                        49.2       3,754                   63.0    

                                                                                                                                                                                                                        

                                                                                                                                                                                                                        

  History of diabetes                                                                                                                                                                                                   

  H/O diabetes n = 5,851                                                                                                                                                                                                

  NO H/O diabetes n = 41,777                                                                                                                                                                                            

                                                                                                                                                                                                                        

  BP \< 130 and \< 85 mmHg                                                             H/O diabetes N = 2,447      H/O diabetes N = 1,366       H/O diabetes N = 585                                                    

                                                                                       NO H/O diabetes 8,453       NO H/O diabetes N = 11,524   NO H/O diabetes N = 12,559                                              

                                                                                                                                                                                                                        

                                                                                       n = 6,801                   n = 9,202                    n = 10,733                                                              

   H/O diabetes                  4,398              75.2    2,775              63.1    1,476                       60.3                         919                          67.3       380                     65.0    \<0.0001

   NO H/O diabetes               32,536             77.9    23,961             73.6    5,325                       63.0                         8,283                        71.9       10,353                  82      

                                                                                                                                                                                                                        

  LDL \< 130 md/dL                                                                     H/O diabetes N = 2,963      H/O diabetes N = 1,617       H/O diabetes N = 705                                                    

                                                                                       NO H/O diabetes N = 8,276   NO H/O diabetes N = 10,396   NO H/O diabetes N = 9,470                                               

                                                                                                                                                                                                                        

                                                                                       n = 8,777                   n = 9,273                    n = 8,278                                                               

   H/O diabetes                  5,285              90.3    4,746              89.8    2,635                       88.9                         1,462                        90.4       649                     92.1    0.57

   NO H/O diabetes               28,142             67.4    21,583             76.7    6,143                       74.2                         7,811                        75.1       7,629                   80.6    

                                                                                                                                                                                                                        

  Casual glucose \< 200 mg/dL                                                          H/O diabetes N = 2,884      H/O diabetes N = 1,596       H/O diabetes N = 745                                                    

                                                                                       NO H/O diabetes N = 8,332   NO H/O diabetes N = 10,305   NO H/O diabetes N = 10,727                                              

                                                                                                                                                                                                                        

                                                                                       n = 10,707                  n = 11,635                   n = 11,356                                                              

   H/O diabetes                  5,225              89.3    4,383              83.9    2,400                       83.2                         1,342                        84.1       641                     86.0    0.015

   NO H/O diabetes               29,634             70.9    29,315             98.9    8,307                       99.7                         10,293                       99.9       10,715                  99.9    

                                                                                                                                                                                                                        

  Fasting glucose \< 100 mg/dL                                                         H/O diabetes N = 1,619                                   H/O diabetes N = 812                    H/O diabetes N = 305            0.24

                                                                                       NO H/O diabetes N = 3,728                                NO H/O diabetes N = 3,992               NO H/O diabetes 2,965           

                                                                                       n = 2,753                   n = 3,146                    n = 2,583                                                               

   H/O diabetes                  2,736              46.8    554                20.2    285                         17.6                         170                          20.9       99                      32.5    

   NO H/O diabetes               10,685             25.6    7,928              74.2    2,468                       66.2                         2,976                        74.6       2,484                   83.8    

                                                                                                                                                                                                                        

  All 3 risk factors                                                                   H/O diabetes N = 2,197      H/O diabetes N = 1,240       H/O diabetes N = 499         \<0.0001                                   

                                                                                       NO H/O diabetes N = 6,050   NO H/O diabetes N = 7,557    NO H/O diabetes N = 6,487                                               

                                                                                                                                                                                                                        

                                                                                       n = 3,596                   n = 4,344                    n = 4,327                                                               

   H/O diabetes                  3,936              67.3    1,754              44.6    929                         42.3                         587                          47.3       238                     47.7    

   NO H/O diabetes               20,094             48.1    10,513             52.3    2,667                       44.1                         3,757                        49.7       4,089                   63.0    
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

P-value compares homogeneity of the odds ratios across groups. CVD = Cardiovascular Disease, BMI = Body Mass Index (weight in kilograms/height in meters^2^), BP = Blood Pressure, LDL = Low density lipoprotein cholesterol, HDL = High density lipoprotein cholesterol. Risk factor control rates are from patients with risk factors documented. Numbers and percentages in table reflect percentage of risk factor documented by BMI type in patients either with or without a history of CVD or DM (i.e., 1,931 = 73% of 2,647 patients who are obese with BP documented with a history of CVD). All 3 risk factors controlled = control of BP + LDL + casual OR fasting glucose. Documentation or control of all 3 risk factors defined as BP, LDL, and fasting or casual glucose below the thresholds indicated.

Discussion
==========

We examined the current state of BMI documentation and documentation and control of associated risk factors by BMI category, based on EHR data from almost 80,000 adult patients seen in a 12-clinic primary care network during 18 months in 2005-2006. Our findings demonstrate variations in risk factor recognition and control for obese persons compared to those of normal weight, as well as for those with and without CVD or type 2 diabetes. We found that documentation of BMI varied widely by clinic site and was overall low. Among patients with a BMI recorded, documentation of most risk factors was higher in patients with obesity compared with normal weight patients; however, control of risk factors was poorer in obesity than normal weight. Patients without a documented history of CVD or diabetes had strikingly more dissimilar rates of documentation and control between weight categories than patients with CVD or diabetes. Overall, patients with obesity with or without CVD or diabetes had lower rates of risk factor documentation and control than may be ideal given their high absolute risk of adverse health outcomes.

Our study builds upon findings from previous studies. Lemay *et al*audited medical records from 465 adult patients seen at a community health center during one week in February of 1999 to evaluate height and weight documentation and obesity diagnosis by the practitioner over a prior six-month period, and found that only 63% of their patient cohort had a height and weight documented \[[@B27]\]. Similar to our study, Lemay looked a group of patients in normal clinical practice; however, we were able to expand upon this study in terms of a far larger study sample as well as a longer sampling frame to assess provision of services (18 months versus 6 months), potentially providing a more accurate picture of risk factor evaluation. Six years after this study and seven years after the establishment of the NHLBI guidelines, we found the percentage of BMI documentation to be essentially the same (63% versus 60.5%). Rifas-Shiman *et al*studied 5,025 members of the same insurance plan and group practice who were a subset of participants from a cohort study and were continuously enrolled since 1999, had a visit in 2000, had a BMI measurement between January 1, 2000 and December 31, 2000, and who did not have medical conditions related to weight loss or CVD. They found that higher BMI was an independent predictor of increased fasting glucose, triglyceride, LDL cholesterol, and HDL cholesterol screening \[[@B28]\]. Rifas-Shiman identified lipid and glucose abnormalities over a two-year period, comparable in time to our study. Neither we nor Rifas-Shiman could evaluate attempts at management, so reasons for increased documentation such as guideline adherence could not be assessed. Our analysis extends prior studies by evaluating whether those with documentation of risk factors had those risk factors in control according to Adult Treatment Panel III (ATP III) metabolic syndrome guidelines for a patient with average cardiovascular risk.

Molenaar *et al*studied rates of treatment and control of hypercholesterolemia, hypertension, and diabetes in normal weight, overweight, and obese subjects with a history of these conditions utilizing a CVD-free subset of the Framingham Heart Study. They found that subjects with hypercholesterolemia and hypertension who were obese were more likely to have these conditions treated than normal weight subjects. Rates of control of hypertension and hypercholesterolemia were uniformly poor and did not differ between weight groups. Rates of control of diabetes were poor among all three weight groups, but subjects who were obese were less likely to have control of fasting blood glucose than normal weight subjects. The goal of our study, however, was different from that of Molenaar. Molenaar studied rates of treatment and control of hypercholesterolemia, hypertension, and diabetes in normal weight, overweight, and obese subjects with a history of these conditions who were free of CVD, a subgroup of patients with a clear indication for BMI screening. Our goal was to evaluate in all patients, both with and without obesity-associated risk factors, the current state of BMI screening and subsequent screening for associated risk factors by BMI group, according to HEDIS and NHLBI guidelines. Molenaar *et al*examined a well-known, standardized study population, where only 196 subjects had missing BMI data. Our population was a non-standardized data source, and our subjects were a mixture of both those with and without CVD and its risk factors, with further subanalysis in patients with a history of CVD and diabetes. Despite these differences, findings from the structured Framingham population and from our analysis of usual clinical care are strikingly similar. This minimizes to a large degree the concern that high rates of missing BMI information could have distorted our findings, and may explain why our percentages of control were higher than those found by Molenaar, albeit still low overall \[[@B29]\].

The rapidly growing prevalence of obesity has pushed BMI assessment to appropriate prominence as a newly proposed reportable HEDIS measure. BMI assessment will be made by several means, including survey of EHRs in health care networks. Our results suggest that the HEDIS *BMI Assessment*measure has potential to provide a timely quality and safety foundation to improve care for patients with obesity. At least in our large primary care network, there clearly is substantial room for improvement in documentation of BMI and documentation and control of BMI-associated risk factors. While height and weight and BMI documentation may reflect individual physician practice styles, by speaking with medical directors we found that lack of height and weight appeared to be a clinic-level and not an individual PCP issue, with height and weight recording often performed or not performed before the PCP sees the patient. It is expected that introduction of the HEDIS *BMI Assessment*measure will improve this state of affairs, although the effectiveness of BMI documentation alone to improve care remains to be demonstrated.

According to our study, patients with already documented CVD or diabetes are more likely to have risk factor documentation and control regardless of BMI category. Those without a documented history of CVD or diabetes demonstrated more variation in risk factor documentation and control by BMI category. At least two recent studies corroborate these data. Melamed *et al*measured BMI in 289 patients in seven family practice clinics in Israel, and found that BMI was documented in only half of obese patients and 39% of overweight patients, and that patients with other chronic medical conditions were more likely to have BMI documented than those without documented comorbidities \[[@B30]\]. Waring *et al*looked at 2,330 overweight and obese patients included in the Cholesterol Education and Research Trial, and found increased odds of overweight or obesity management in relation to weight-related comorbidities for those with moderate or severe obesity \[[@B31]\].

Risk factor control appears to be related to a previously diagnosed risk factor and not to obesity. These findings become even more relevant in light of recent studies that demonstrate increased CVD risk in patients who are overweight and obese compared to normal weight patients, independent of hypertension and hypercholesterolemia \[[@B32]\]. This implies an important need to recognize overweight and obesity, ideally using a simple technique such as BMI, in order to enhance CVD and diabetes complications prevention. Our findings suggest that PCPs are aware of CVD, diabetes, and obesity as strongly tied risk factors, but that they may not recognize obesity as a risk factor for morbidity and mortality independent of these other comorbidities.

Limitations
-----------

Our results must be interpreted with some limitations in mind. This is clinical, not research, data, which naturally suffers from information that is missing and inconsistent in its recording. We carefully addressed missingness with multiple methods of ascertaining exposures, and addressed inconsistencies in data recording by removal of clinically illogical extreme outliers. Evaluation of BMI documentation rates, with the inherent missing data, was a goal of our study. Furthermore, despite its limitations, evaluation of clinical data is a strength of this study, in that it provides a glimpse into current obesity care and insights into improving this practice. Although our data were derived from a single academic health care network, the sites included a representative mixture of urban, suburban, and hospital-based practices, making our findings generalizable and potentially replicable. Another important strength of our study is the use of a long-standing, widely used EHR encompassing all aspects of patient care from a large network of diverse clinics and patient populations. EHRs, while not a perfect tool due to the potential for improperly entered or overlooked data, have great potential for research, with studies showing that EHRs have potential for increasing documentation and treatment of obese patients \[[@B33]\]. Finally while there were differences seen in the percentages of documentation of risk factors, this may be due mainly to test indication, whereby certain tests such as cholesterol levels are more likely to be ordered on most patients than fasting glucose. However, our overall documentation numbers were large enough to yield consistent results across BMI categories.

Conclusions
===========

It is well-accepted that intentional weight loss mitigates many of the risk factors associated with obesity. Despite rising rates of obesity, physicians appear not to routinely assess BMI during office visits \[[@B34]\]. According to the NCQA, multiple organizations recommend measuring BMI as part of the routine physical examination \[[@B16],[@B9],[@B10],[@B14],[@B15]\]. Treatment recommendations for obesity depend on ascertainment of BMI and complications of obesity. Therefore, screening for BMI and comorbidities could change patient management. In light of new studies implicating overweight and obesity as independent risk factors for CVD, recognition of BMI becomes even more important in the primary care setting. We examined a large, diverse primary care network to evaluate current care and found that EHRs will be a useful tool to evaluate BMI assessment. We demonstrate substantial opportunities for improvement in the assessment and control of adiposity and associated risk factors that are needed to address the US obesity epidemic.
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